[Excessive sweating related to hydromorphone]

Fiche publication


Date publication

février 2009

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BONNOTTE Bernard, Dr DEVILLIERS Hervé


Tous les auteurs :
Vinit J, Devilliers H, Audia S, Leguy V, Mura H, Falvo N, Berthier S, Besancenot JF, Bonnotte B, Lorcerie B

Résumé

Diffuse and abundant sweating in a middle age patient evolving for several weeks should raise suspicion of malignant lymphoma and infectious or neuroendocrine disorders before considering a drug origin. We report a patient who presented with severe and invalidating excessive sweating related to hydromorphone therapy for vertebral pain. Amongst their many reported side-effects, excessive sweating disappearing with discontinuation of the drug have been reported with some opiates.

Référence

Rev Med Interne. 2009 Feb;30(2):190-1